LAVA Medtech Acquisition Probability of Future Stock Price Finishing Over 10.35

LVACDelisted Stock  USD 10.44  0.00  0.00%   
LAVA Medtech's future price is the expected price of LAVA Medtech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of LAVA Medtech Acquisition performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
Please specify LAVA Medtech's target price for which you would like LAVA Medtech odds to be computed.

LAVA Medtech Target Price Odds to finish over 10.35

The tendency of LAVA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 10.35  in 90 days
 10.44 90 days 10.35 
under 95
Based on a normal probability distribution, the odds of LAVA Medtech to stay above $ 10.35  in 90 days from now is under 95 (This LAVA Medtech Acquisition probability density function shows the probability of LAVA Stock to fall within a particular range of prices over 90 days) . Probability of LAVA Medtech Acquisition price to stay between $ 10.35  and its current price of $10.44 at the end of the 90-day period is about 85.19 .
Given the investment horizon of 90 days LAVA Medtech Acquisition has a beta of -0.0341. This indicates as returns on the benchmark increase, returns on holding LAVA Medtech are expected to decrease at a much lower rate. During a bear market, however, LAVA Medtech Acquisition is likely to outperform the market. Additionally LAVA Medtech Acquisition has an alpha of 0.0092, implying that it can generate a 0.009198 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   LAVA Medtech Price Density   
       Price  

Predictive Modules for LAVA Medtech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LAVA Medtech Acquisition. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.4410.4410.44
Details
Intrinsic
Valuation
LowRealHigh
8.858.8511.48
Details
Naive
Forecast
LowNextHigh
10.4610.4610.46
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.4010.4210.45
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as LAVA Medtech. Your research has to be compared to or analyzed against LAVA Medtech's peers to derive any actionable benefits. When done correctly, LAVA Medtech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in LAVA Medtech Acquisition.

LAVA Medtech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. LAVA Medtech is not an exception. The market had few large corrections towards the LAVA Medtech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LAVA Medtech Acquisition, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LAVA Medtech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.01
β
Beta against Dow Jones-0.03
σ
Overall volatility
0.03
Ir
Information ratio -0.68

LAVA Medtech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LAVA Medtech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LAVA Medtech Acquisition can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LAVA Medtech is not yet fully synchronised with the market data
LAVA Medtech has a very high chance of going through financial distress in the upcoming years
LAVA Medtech Acquisition currently holds about 1.15 M in cash with (658.82 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Over 92.0% of the company shares are owned by institutional investors

LAVA Medtech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LAVA Stock often depends not only on the future outlook of the current and potential LAVA Medtech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LAVA Medtech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.4 M
Cash And Short Term Investments1.2 M

LAVA Medtech Technical Analysis

LAVA Medtech's future price can be derived by breaking down and analyzing its technical indicators over time. LAVA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LAVA Medtech Acquisition. In general, you should focus on analyzing LAVA Stock price patterns and their correlations with different microeconomic environments and drivers.

LAVA Medtech Predictive Forecast Models

LAVA Medtech's time-series forecasting models is one of many LAVA Medtech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LAVA Medtech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about LAVA Medtech Acquisition

Checking the ongoing alerts about LAVA Medtech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LAVA Medtech Acquisition help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LAVA Medtech is not yet fully synchronised with the market data
LAVA Medtech has a very high chance of going through financial distress in the upcoming years
LAVA Medtech Acquisition currently holds about 1.15 M in cash with (658.82 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Over 92.0% of the company shares are owned by institutional investors
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in LAVA Stock

If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk